Comparison of Clinical Outcomes After Transcatheter vs. Minimally Invasive Cardiac Surgery Closure for Atrial Septal Defect

DOI Web Site Web Site PubMed 参考文献46件
  • Kodaira Masaki
    Department of Cardiology, Keio University School of Medicine Department of Cardiology, Ashikaga Red Cross Hospital
  • Kawamura Akio
    Department of Cardiology, Keio University School of Medicine Department of Cardiology, National Defense Medical College
  • Okamoto Kazuma
    Department of Cardiovascular Surgery, Keio University School of Medicine
  • Kanazawa Hideaki
    Department of Cardiology, Keio University School of Medicine
  • Minakata Yugo
    Department of Cardiology, Keio University School of Medicine
  • Murata Mitsushige
    Department of Cardiology, Keio University School of Medicine Department of Laboratory Medicine, Keio University School of Medicine
  • Shimizu Hideyuki
    Department of Cardiovascular Surgery, Keio University School of Medicine
  • Fukuda Keiichi
    Department of Cardiology, Keio University School of Medicine

この論文をさがす

説明

<p>Background:Percutaneous closure has replaced surgery for the majority of cases of secundum atrial septal defect (ASD). However, technological advances have made contemporary minimally invasive cardiac surgery (MICS) less invasive than conventional surgery. The aim of this study was to compare clinical outcomes of percutaneous closure of secundum ASD with those of contemporary MICS.</p><p>Methods and Results:We conducted a single-center retrospective study of 354 patients with ASD treated either with the Amplatzer Septal Occluder (134 patients) or MICS (220 patients) between 2000 and 2013. Success rates and the incidence of complications were compared. The success rates were 98% for percutaneous closure and 100% for MICS. There were no deaths in either group. Major complications occurred in 2 patients (1.5%) who underwent percutaneous closure and in 8 patients (3.6%) treated with MICS (P=0.16). Minor complications occurred in 15 patients (11.2%) who underwent percutaneous closure and in 46 patients (20.9%) treated with MICS (P=0.02). On multivariate analysis, MICS (odds ratio [OR]: 2.91, 95% confidence interval [CI]: 1.46–5.81; P=0.002) and age >70 years (OR: 3.50, 95% CI: 1.40–8.75; P=0.008) were independent predictors of complications.</p><p>Conclusions:Percutaneous closure and MICS had high success rates without deaths. For ASD patients with a suitable anatomy, percutaneous closure can be considered as the first therapeutic option.</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 81 (4), 543-551, 2017

    一般社団法人 日本循環器学会

参考文献 (46)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ